Huahai US, Inc. develops, acquires, licenses, registers, markets, and distributes prescribed generic pharmaceutical products. It offers cardiovascular, CNS, Alzheimer’s, anti-diabetes, and anti-HIV products to the US market. Huahai US, Inc. is a wholly owned subsidiary of Zhejiang Huahai Pharmaceutical Co. Ltd., the first Chinese manufacturer approved by the US FDA in 2007 for manufacturing finished products. It was founded in 2004 and is located in Cranbury, New Jersey.
| Website | http://www.huahaipharm.com |
| Revenue | $1.2 billion |
| Employees | 26 (16 on RocketReach) |
| Founded | 2004 |
| Phone | +86 576 8501 6116 |
| Fax | +86 576 8599 1062 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Web Rank | 388539 |
| Web Visits | 75460 |
| Keywords | Generic Pharmaceuticals, Pharmaceutical Products, Prescription Drugs, Healthcare, Drug Development, Generic Drug Manufacturing, Pharmaceutical Marketing, Drug Registration, Drug Distribution, Cardiovascular Drugs, Drug Licensing, Drug Acquisition, Api, Cns Drugs |
| Competitors | Torrent Pharmaceuticals Ltd, Sandoz, SUN PHARMA, Dr. Reddy's Laboratories, Aurobindo Pharma, Alvogen, Lupin Limited, Mylan Belgium, Zydus Cadila Healthcare Limited, Teva Neuroscience +41 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Huahai US, Inc. employee's phone or email?
The Huahai US, Inc. annual revenue was $1.2 billion in 2026.
Bin He is the CEO of Huahai US, Inc..
16 people are employed at Huahai US, Inc..
The NAICS codes for Huahai US, Inc. are [3254, 32541, 32, 325].
The SIC codes for Huahai US, Inc. are [28, 283].